These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8461554)

  • 41. Zinc excretion in osteoporotic women.
    Herzberg M; Foldes J; Steinberg R; Menczel J
    J Bone Miner Res; 1990 Mar; 5(3):251-7. PubMed ID: 2333784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship of vitamin D status to bone mineral density in an Italian population of postmenopausal women.
    Malavolta N; Pratelli L; Frigato M; Mulè R; Mascia ML; Gnudi S
    Osteoporos Int; 2005 Dec; 16(12):1691-7. PubMed ID: 15959621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pathophysiology of osteoporosis and bone density determination].
    Dambacher MA; Haas HG; Rüegsegger P
    Internist (Berl); 1991 Feb; 32(2):63-9. PubMed ID: 2032790
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol.
    Ringe JD; Schacht E
    Rheumatol Int; 2004 Jul; 24(4):189-97. PubMed ID: 15232715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria.
    Vezzoli G; Rubinacci A; Bianchin C; Arcidiacono T; Giambona S; Mignogna G; Fochesato E; Terranegra A; Cusi D; Soldati L
    Am J Kidney Dis; 2003 Dec; 42(6):1177-83. PubMed ID: 14655189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis.
    Nuti R; Bianchi G; Brandi ML; Caudarella R; D'Erasmo E; Fiore C; Isaia GC; Luisetto G; Muratore M; Oriente P; Ortolani S
    Rheumatol Int; 2006 Mar; 26(5):445-53. PubMed ID: 16283320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy.
    Lau KH; Baylink DJ
    Calcif Tissue Int; 1999 Oct; 65(4):295-306. PubMed ID: 10485982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photon absorptiometry studies in osteoporosis.
    Christiansen C
    Acta Obstet Gynecol Scand Suppl; 1985; 130():67-70. PubMed ID: 3893022
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of 1alpha-hydroxycholecalciferol in senile osteoporosis and in bone loss following prednisone treatment.
    Sorensen OH; Lund B; Friis TH; Hjorth L; Reimann I; Kjaer I; Andersen RB
    Isr J Med Sci; 1977 Mar; 13(3):253-8. PubMed ID: 852974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of ipriflavone in established osteoporosis and long-term safety.
    Agnusdei D; Bufalino L
    Calcif Tissue Int; 1997; 61 Suppl 1():S23-7. PubMed ID: 9263613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis.
    Gallagher JC
    Metabolism; 1990 Apr; 39(4 Suppl 1):27-9. PubMed ID: 2325568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The postmenopausal form of osteoporosis].
    Rodionova SS
    Ter Arkh; 1997; 69(10):21-4. PubMed ID: 9471783
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevention of postmenopausal bone loss by low and conventional doses of calcitriol or conjugated equine estrogen.
    Ongphiphadhanakul B; Piaseu N; Tung SS; Chailurkit L; Rajatanavin R
    Maturitas; 2000 Feb; 34(2):179-84. PubMed ID: 10714913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
    Gallagher JC; Riggs BL; DeLuca HF
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the drug therapy for established osteoporosis by dual-energy x-ray absorptiometry.
    Shiota E
    Fukuoka Igaku Zasshi; 1998 Jun; 89(6):172-8. PubMed ID: 9695314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Should bisphosphonate treatment be used for super-old patients with osteoporosis?].
    Harada A; Yamamoto S; Kurato S; Iwase T; Inoue K; Sasaki Y; Tanaka T; Fujita M; Nakano T; Ando F
    Nihon Ronen Igakkai Zasshi; 2006 Jul; 43(4):459-61. PubMed ID: 16937933
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women.
    Dawson-Hughes B; Dallal GE; Krall EA; Harris S; Sokoll LJ; Falconer G
    Ann Intern Med; 1991 Oct; 115(7):505-12. PubMed ID: 1883119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish perimenopausal women.
    Hansen TS; Abrahamsen B; Henriksen FL; Hermann AP; Jensen LB; Hørder M; Gram J
    Bone; 1998 May; 22(5):571-5. PubMed ID: 9600794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypomagnesaemia after small bowel resection: treatment with 1 alpha-hydroxylated vitamin D metabolites.
    Selby PL; Peacock M; Bambach CP
    Br J Surg; 1984 May; 71(5):334-7. PubMed ID: 6547069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
    Tolino A; Romano L; Ronsini S; Riccio S; Montemagno U
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.